Institutional investors purchased a net $888.9 thousand shares of CYCC during the quarter ended September 2014, and now own 17.09% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EASTERN CAPITAL LTD. Bought 857.1 Thousand shares of Cyclacel Pharmaceuticals ...
SARISSA CAPITAL MANAGEMENT LP Bought 376.0 Thousand shares of Cyclacel Pharmaceuticals ...